Ignite Creation Date:
2025-12-24 @ 6:57 PM
Ignite Modification Date:
2026-01-02 @ 6:11 AM
Study NCT ID:
NCT02281357
Status:
COMPLETED
Last Update Posted:
2019-03-15
First Post:
2014-10-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 3 Study to Evaluate the Efficacy & Safety of Tralokinumab in Adults & Adolescents With OCS Dependent Asthma
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-02-19
Start Date Type:
ACTUAL
Primary Completion Date:
2017-09-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-09-07
Completion Date Type:
ACTUAL
First Submit Date:
2014-10-30
First Submit QC Date:
None
Study First Post Date:
2014-11-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-03-01
Results First Submit QC Date:
None
Results First Post Date:
2018-05-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-02-27
Last Update Post Date:
2019-03-15
Last Update Post Date Type:
ACTUAL